Pre-Tax Income: Company's earnings or loss before taxes on income have been accounted for.
Arrowhead Pharmaceuticals, Inc. (ARWR) had Pre-Tax Income of $-178.91M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
$75.25M |
|
$-194.28M |
|
-- |
|
$75.25M |
|
$245.35M |
|
$-170.09M |
|
$-8.81M |
|
|
Pre-Tax Income |
$-178.91M |
$-176.44M |
|
$-178.92M |
|
$-178.92M |
|
$-178.92M |
|
$-176.45M |
|
$-170.09M |
|
$-164.28M |
|
143.38M |
|
143.38M |
|
$-1.36 |
|
$-1.36 |
|
| Balance Sheet Financials | |
$1.67B |
|
$373.30M |
|
$440.60M |
|
$2.11B |
|
$283.35M |
|
$824.07M |
|
$1.36B |
|
$1.65B |
|
$466.04M |
|
$460.45M |
|
$466.04M |
|
141.13M |
|
| Cash Flow Statement Financials | |
$-79.55M |
|
$-874.34M |
|
$780.52M |
|
$226.55M |
|
$54.76M |
|
$-171.79M |
|
$50.91M |
|
$-38.43M |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.90 |
|
-- |
|
-- |
|
0.64 |
|
1.85 |
|
100.00% |
|
-226.03% |
|
-226.03% |
|
-- |
|
-237.74% |
|
-258.17% |
|
$-88.11M |
|
-- |
|
-- |
|
-- |
|
0.04 |
|
-- |
|
8.80 |
|
10.23 |
|
-38.39% |
|
-38.86% |
|
-8.47% |
|
-13.87% |
|
$3.30 |
|
$-0.61 |
|
$-0.55 |
|